MET and non-small cell lung carcinoma: The MET proto-oncogene receptor tyrosine kinase and its ligand, the hepatocyte growth factor were first characterized in the mid-1980s and their involvement in non-small-cell lung cancer tumorigenesis was first described in the 1990s [6, 19–21].